JIKOMENEKIKIGENNODATSUZUISEISHITSUKAN*TOKUNITAHATSUSEIKOKASHOOSHOCHISURUTAMENOIYAKUSOSEIBUTSU

摘要

The invention relates to a method for treating demyelinization clinical patterns of autoimmune origin, particularly the multiple sclerosis. The invention further relates to a pharmaceutical composition useful for the treatment of demyenilization clinical patterns of autoimmune origin, particularly the multiple sclerosis. The invention also relates to the use of ethyl (+)-apovincaminate for the preparation of a pharmaceutical composition useful for the treatment of demyelinization clinical patterns of autoimmune origin, particularly the multiple sclerosis.